In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Arcturus Therapeutics Holdings Inc (NASDAQ: ARCT) closed the day trading at $19.79 down -3.70% from the previous closing price of $20.55. In other words, the price has decreased by -$3.70 from its previous closing price. On the day, 0.51 million shares were traded. ARCT stock price reached its highest trading level at $20.065 during the session, while it also had its lowest trading level at $18.75.
Ratios:
For a better understanding of ARCT, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 1.55 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 50.76. For the most recent quarter (mrq), Quick Ratio is recorded 3.26 and its Current Ratio is at 3.26. In the meantime, Its Debt-to-Equity ratio is 0.12 whereas as Long-Term Debt/Eq ratio is at 0.10.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Canaccord Genuity on December 13, 2023, initiated with a Buy rating and assigned the stock a target price of $90.
On July 24, 2023, William Blair started tracking the stock assigning a Outperform rating and target price of $71.
H.C. Wainwright Upgraded its Neutral to Buy on May 11, 2023, whereas the target price for the stock was revised from $19 to $51.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jun 12 ’24 when SASSINE ANDY sold 50,000 shares for $32.03 per share. The transaction valued at 1,601,500 led to the insider holds 220,526 shares of the business.
Chivukula Pad sold 114 shares of ARCT for $5,130 on Jun 05 ’24. The Chief Scientific Officer & COO now owns 447,334 shares after completing the transaction at $45.00 per share. On Jun 03 ’24, another insider, Chivukula Pad, who serves as the Chief Scientific Officer & COO of the company, sold 26,000 shares for $40.01 each. As a result, the insider received 1,040,234 and left with 447,448 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ARCT now has a Market Capitalization of 532980352 and an Enterprise Value of 296975040. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.69 while its Price-to-Book (P/B) ratio in mrq is 2.02. Its current Enterprise Value per Revenue stands at 2.385 whereas that against EBITDA is -2.49.
Stock Price History:
Over the past 52 weeks, ARCT has reached a high of $45.00, while it has fallen to a 52-week low of $17.52. The 50-Day Moving Average of the stock is -28.89%, while the 200-Day Moving Average is calculated to be -32.37%.
Shares Statistics:
Over the past 3-months, ARCT traded about 587.71K shares per day on average, while over the past 10 days, ARCT traded about 368970 shares per day. A total of 26.83M shares are outstanding, with a floating share count of 24.63M. Insiders hold about 8.53% of the company’s shares, while institutions hold 103.67% stake in the company. Shares short for ARCT as of 1721001600 were 5211849 with a Short Ratio of 8.87, compared to 1718323200 on 4382378. Therefore, it implies a Short% of Shares Outstanding of 5211849 and a Short% of Float of 30.44.
